Don't Just Read the News, Understand It.
Published loading...Updated

CAR-T Cells That Secrete CD19 Antibodies Effective Against B-ALL

Summary by Inside Precision Medicine
Researchers at Josep Carreras Leukaemia Research Institute and Hospital 12 de Octubre in Spain have tested a new CAR-T immunotherapy that can effectively maintain its treatment efficacy longer in B-cell acute lymphoblastic leukemia (B-ALL) versus current therapies. This new approach, which targeted the CD19 protein, is the latest advance in improving therapeutic response for patients who have relapsed or did do not respond to current standard tr…
DisclaimerRead with caution - this story is only being covered by one news source that has a ‘low factuality’ rating, which means the outlet has a history of poor reporting practices. Learn more about factuality ratings here.

4 Articles

All
Left
Center
Right
1
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • 100% of the sources lean Right
100% Right
Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

sport.es broke the news in on Tuesday, May 27, 2025.
Sources are mostly out of (0)

Similar News Topics